Key Insights

Highlights

Success Rate

71% trial completion

Treatment Research

18 treatments under study, led by Melatonin

Research Leaders

17 sponsors active, led by Stanford University

Related Conditions

Often studied with 15 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

71.4%

-15.2% vs benchmark

Late-Stage Pipeline

36%

4 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results71% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (3)
Phase 1 (1)
Phase 3 (1)
Phase 4 (3)

Trial Status

Completed5
Unknown2
Recruiting2
Terminated2

Trial Success Rate

71.4%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (11)

Research Network

Common Treatments

  • Melatonin3
  • Constant Routine1
  • Light Therapy1
  • Melatonin And Light Therapy1
  • Bright Light1

Active Sponsors

  • Stanford University3
  • Brigham and Women's Hospital3
  • Sheba Medical Center1
  • University of Pittsburgh1
  • Uppsala University1

Top Investigators

Related Conditions

  • Delayed Sleep Phase3
  • Sleep Disorders Circadian Rhythm3
  • Advanced Sleep Phase Syndrome Asps3
  • Shift Work Type Circadian Rhythm Sleep Disorder2
  • Sleep Wake Disorders2

Activity Timeline